Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Squamous Cell Carcinoma of Head and Neck 80Head and Neck Neoplasms 72Nasopharyngeal Carcinoma 61Prostatic Neoplasms 51Oropharyngeal Neoplasms 30Carcinoma, Non-Small-Cell Lung 27Rectal Neoplasms 23Carcinoma, Squamous Cell 23Breast Neoplasms 23Glioblastoma 22Uterine Cervical Neoplasms 18Carcinoma 18Neoplasm Metastasis 16Brain Neoplasms 16Nasopharyngeal Neoplasms 15Pancreatic Neoplasms 14Lung Neoplasms 13Gliosarcoma 13Glioma 13Esophageal Neoplasms 13Radiation Injuries 12Mouth Neoplasms 12Laryngeal Neoplasms 12Esophageal Squamous Cell Carcinoma 12Astrocytoma 12Tongue Neoplasms 11Hypopharyngeal Neoplasms 11Sarcoma 10Neoplasms 10Salivary Gland Neoplasms 8

Interventions

luprolide acetate gel depot 1bicalutamide 1Radiotherapy, Intensity-Modulated 1Leuprolide 1Goserelin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
PSA Level Greater Than Two × Radiotherapy, Intensity-Modulated × Clear all
NCT00544830 2026-05-15

Hormone Therapy and Intensity-Modulated Radiation Therapy in Treating Patients With Metastatic Prostate Cancer

City of Hope Medical Center

Phase 2 Active not recruiting
29 enrolled 12 charts
Genitourinary

PSA Level Greater Than Two

Data powered by HemOnc (CC BY 4.0) Colophon âš¡